Result: One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2022

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

The journal of clinical investigation. - 132, 24 (2022) , e163657, ISSN: 1558-8238

*DOI*:

10.1172/jci163657

*Result*: One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients